These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 27743434)
1. Molecular Analysis of Ganciclovir-Resistant Cytomegalovirus in Renal Transplant Recipients with High Viral Load. Sohrabi M; Behzadian F; Hosseini SM; Lashini H Arch Iran Med; 2016 Oct; 19(10):700-703. PubMed ID: 27743434 [TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir. Boivin G; Goyette N; Rollag H; Jardine AG; Pescovitz MD; Asberg A; Ives J; Hartmann A; Humar A Antivir Ther; 2009; 14(5):697-704. PubMed ID: 19704173 [TBL] [Abstract][Full Text] [Related]
3. Ganciclovir-resistant post-transplant cytomegalovirus infection due to combined deletion mutation at codons 595-596 of the UL97 gene. Leung PYM; Tran T; Testro A; Paizis K; Kwong J; Whitlam JB Transpl Infect Dis; 2019 Dec; 21(6):e13168. PubMed ID: 31498954 [TBL] [Abstract][Full Text] [Related]
4. Molecular Epidemiology of Cytomegalovirus UL97 and UL54 variants in Taiwan. Yang SL; Lin TW; Lin HC; Wang HY; Chang PY; Wang PN; Yang S; Lu JJ J Microbiol Immunol Infect; 2021 Oct; 54(5):971-978. PubMed ID: 33632621 [TBL] [Abstract][Full Text] [Related]
5. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients. Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359 [TBL] [Abstract][Full Text] [Related]
6. Genotypic resistance of cytomegalovirus to antivirals in hematopoietic stem cell transplant recipients from Portugal: A retrospective study. Campos AB; Ribeiro J; Pinho Vaz C; Campilho F; Branca R; Campos A; Baldaque I; Medeiros R; Boutolleau D; Sousa H Antiviral Res; 2017 Feb; 138():86-92. PubMed ID: 27887982 [TBL] [Abstract][Full Text] [Related]
7. Ganciclovir resistance mutations in UL97 and UL54 genes of Human cytomegalovirus isolates resistant to ganciclovir. Foulongne V; Turrière C; Diafouka F; Abraham B; Lastere S; Segondy M Acta Virol; 2004; 48(1):51-5. PubMed ID: 15230476 [TBL] [Abstract][Full Text] [Related]
8. Dynamics of coexisting HCMV-UL97 and UL54 drug-resistance associated mutations in patients after haematopoietic cell transplantation. Göhring K; Wolf D; Bethge W; Mikeler E; Faul C; Vogel W; Vöhringer MC; Jahn G; Hamprecht K J Clin Virol; 2013 May; 57(1):43-9. PubMed ID: 23375740 [TBL] [Abstract][Full Text] [Related]
9. Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir or ganciclovir prophylaxis. Boivin G; Goyette N; Gilbert C; Covington E J Med Virol; 2005 Nov; 77(3):425-9. PubMed ID: 16173018 [TBL] [Abstract][Full Text] [Related]
10. A deletion at CMV UL54 codon 524 without co-existing resistance-associated mutation at UL97 confers resistance to ganciclovir: A case report. Green CB; O'Riordan A; Griffiths P; Haque T J Clin Virol; 2016 Jul; 80():24-6. PubMed ID: 27131599 [TBL] [Abstract][Full Text] [Related]
11. Incidence and characterization of cytomegalovirus resistance mutations among pediatric solid organ transplant patients who received valganciclovir prophylaxis. Martin M; Goyette N; Ives J; Boivin G J Clin Virol; 2010 Apr; 47(4):321-4. PubMed ID: 20138805 [TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina. Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748 [TBL] [Abstract][Full Text] [Related]
13. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes. Oshima K; Kanda Y; Kako S; Asano-Mori Y; Watanabe T; Motokura T; Chiba S; Shiraki K; Kurokawa M J Med Virol; 2008 Oct; 80(10):1769-75. PubMed ID: 18712833 [TBL] [Abstract][Full Text] [Related]
15. Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance. Fischer L; Imrich E; Sampaio KL; Hofmann J; Jahn G; Hamprecht K; Göhring K Antiviral Res; 2016 Jul; 131():1-8. PubMed ID: 27058773 [TBL] [Abstract][Full Text] [Related]
16. Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients. Marfori JE; Exner MM; Marousek GI; Chou S; Drew WL J Clin Virol; 2007 Feb; 38(2):120-5. PubMed ID: 17157554 [TBL] [Abstract][Full Text] [Related]
17. Human cytomegalovirus (CMV) UL97 D605E mutation has a higher prevalence in infants with primary CMV infection compared with transplant recipients with CMV recurrence. Sun J; Cao G; Zhang L; Zhang Y; Zhao Z; Hu J; Ji Y Transplant Proc; 2012 Dec; 44(10):3022-5. PubMed ID: 23195018 [TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations. Scott GM; Isaacs MA; Zeng F; Kesson AM; Rawlinson WD J Med Virol; 2004 Sep; 74(1):85-93. PubMed ID: 15258973 [TBL] [Abstract][Full Text] [Related]
19. Lack of resistance-associated mutations in UL54 and UL97 genes of circulating cytomegalovirus strains isolated in a medical center in Taiwan. Shao PL; Lu MY; Liau YJ; Kao CL; Chang SY; Huang LM J Formos Med Assoc; 2012 Aug; 111(8):456-60. PubMed ID: 22939665 [TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus infection and ganciclovir resistance caused by UL97 mutations in pediatric transplant recipients. Kim YJ; Boeckh M; Cook L; Stempel H; Jerome KR; Boucek R; Burroughs L; Englund JA Transpl Infect Dis; 2012 Dec; 14(6):611-7. PubMed ID: 23198963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]